These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 35952435

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [In vitro activity of β-lactamase inhibitors avibanvctam and relebactam in combination with β-lactams against multidrug-resistant Mycobacterium tuberculosis and mutations of resistance genes].
    Shi J, Zheng DW, Ma XG, Su RY, Zhu YK, Wang SH, Chang WJ, Sun GQ, Sun DY.
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Aug 12; 46(8):797-805. PubMed ID: 37536990
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New Conformations of Acylation Adducts of Inhibitors of β-Lactamase from Mycobacterium tuberculosis.
    Tassoni R, Blok A, Pannu NS, Ubbink M.
    Biochemistry; 2019 Feb 19; 58(7):997-1009. PubMed ID: 30632739
    [Abstract] [Full Text] [Related]

  • 7. Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinations.
    Kurz SG, Wolff KA, Hazra S, Bethel CR, Hujer AM, Smith KM, Xu Y, Tremblay LW, Blanchard JS, Nguyen L, Bonomo RA.
    Antimicrob Agents Chemother; 2013 Dec 19; 57(12):6085-96. PubMed ID: 24060876
    [Abstract] [Full Text] [Related]

  • 8. The G132S Mutation Enhances the Resistance of Mycobacterium tuberculosis β-Lactamase against Sulbactam.
    van Alen I, Chikunova A, Safeer AA, Ahmad MUD, Perrakis A, Ubbink M.
    Biochemistry; 2021 Jul 20; 60(28):2236-2245. PubMed ID: 34250791
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
    Davies Forsman L, Giske CG, Bruchfeld J, Schön T, Juréen P, Ängeby K.
    Int J Mycobacteriol; 2015 Mar 20; 4 Suppl 1():80-1. PubMed ID: 27128620
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.
    Wang F, Cassidy C, Sacchettini JC.
    Antimicrob Agents Chemother; 2006 Aug 20; 50(8):2762-71. PubMed ID: 16870770
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics.
    Flores AR, Parsons LM, Pavelka MS.
    Microbiology (Reading); 2005 Feb 20; 151(Pt 2):521-532. PubMed ID: 15699201
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mycobacterium tuberculosis β-lactamase variant reduces sensitivity to ampicillin/avibactam in a zebrafish-Mycobacterium marinum model of tuberculosis.
    van Alen I, Aguirre García MA, Maaskant JJ, Kuijl CP, Bitter W, Meijer AH, Ubbink M.
    Sci Rep; 2023 Sep 16; 13(1):15406. PubMed ID: 37717068
    [Abstract] [Full Text] [Related]

  • 20. Tuberculosis and beta-lactam antibiotics.
    Gun MA, Bozdogan B, Coban AY.
    Future Microbiol; 2020 Jul 16; 15():937-944. PubMed ID: 32762449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.